Search company, investor...

Bionica

getbionica.com

Founded Year

2005

Stage

Seed VC | Alive

Total Raised

$250K

Last Raised

$250K | 15 yrs ago

About Bionica

Bionica is a Healthcare/Medical Devices & Equipment company based in Providence, Rhode Island. Bionica has received investment from Slater Technology Fund.

Headquarters Location

84 Ship Street

Providence, Rhode Island, 02903,

United States

401-490-6838

Missing: Bionica's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Bionica's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Bionica News

Bionica files for bankruptcy amid legal dispute over diabetes device

Jul 6, 2021

A local medical equipment manufacturer has been mired in a long legal dispute over its diabetes pumps.

Jan 24, 2020
Bionica Labs

Bionica Frequently Asked Questions (FAQ)

  • When was Bionica founded?

    Bionica was founded in 2005.

  • Where is Bionica's headquarters?

    Bionica's headquarters is located at 84 Ship Street, Providence.

  • What is Bionica's latest funding round?

    Bionica's latest funding round is Seed VC.

  • How much did Bionica raise?

    Bionica raised a total of $250K.

  • Who are the investors of Bionica?

    Investors of Bionica include Slater Technology Fund.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.